Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies
J Clin Oncol
.
2024 Dec 11:JCO2402375.
doi: 10.1200/JCO-24-02375.
Online ahead of print.
Author
Simon J Cook
1
Affiliation
1
Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
PMID:
39661912
DOI:
10.1200/JCO-24-02375
No abstract available